Literature DB >> 11521749

Increased kynurenic acid in the brain after neonatal asphyxia.

H Baran1, B Kepplinger, M Herrera-Marschitz, K Stolze, G Lubec, H Nohl.   

Abstract

In the brain, L-kynurenine is an intermediate for the formation of kynurenic acid, a metabolite with neuroprotective activities, and a substrate for the synthesis of 3-hydroxy-kynurenine, a metabolite with neurotoxic properties. In the present study, alterations of L-kynurenine, 3-hydroxy-kynurenine and kynurenic acid levels were examined in the brain of neonatal (10 minutes old) rats after 5, 10, 15 or 20 minutes of asphyxia, and in the brain of the corresponding caesarean-delivered controls, using sensitive high-performance liquid chromatographic methods. Among kynurenines we found a marked time-dependent increase of kynurenic acid levels, a moderately delayed increase of 3-hydroxy-kynurenine, and a trend for a decrease of L-kynurenine content. Thus, the brain reacted rapidly to the oxygen deficit by increasing kynurenic acid levels by 44% already after 5 minutes of asphyxia, and the most prominent elevation of kynurenic acid (302% of control) was found after 20 minutes of asphyxia--the critical time limit of survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521749     DOI: 10.1016/s0024-3205(01)01215-2

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Structure, expression, and function of kynurenine aminotransferases in human and rodent brains.

Authors:  Qian Han; Tao Cai; Danilo A Tagle; Jianyong Li
Journal:  Cell Mol Life Sci       Date:  2009-10-15       Impact factor: 9.261

2.  Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice.

Authors:  Francesca M Notarangelo; Sarah Beggiato; Robert Schwarcz
Journal:  Dev Neurosci       Date:  2019-05-22       Impact factor: 2.984

Review 3.  Involvement of kynurenines in Huntington's disease and stroke-induced brain damage.

Authors:  Trevor W Stone; Caroline M Forrest; Nicholas Stoy; L Gail Darlington
Journal:  J Neural Transm (Vienna)       Date:  2011-06-22       Impact factor: 3.575

Review 4.  Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

Authors:  Francesca M Notarangelo; Ana Pocivavsek
Journal:  Neuropharmacology       Date:  2016-03-02       Impact factor: 5.250

5.  Endogenous Kynurenine Aminotransferases Inhibitor is Proposed to Act as "Glia Depressing Factor" (GDF).

Authors:  Halina Baran; Berthold Kepplinger; Markus Draxler
Journal:  Int J Tryptophan Res       Date:  2010-05-11

6.  The involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.

Authors:  Anna Zinger; Carlos Barcia; Maria Trinidad Herrero; Gilles J Guillemin
Journal:  Parkinsons Dis       Date:  2011-06-03

7.  Carotid surgery affects plasma kynurenic acid concentration: a pilot study.

Authors:  Piotr Terlecki; Paulina Pawlik; Adam Iwaniuk; Tomasz Kocki; Stanisław Przywara; Marek Ilzecki; Tomasz Zubilewicz; Michał Kowalczyk; Jolanta Parada-Turska; Wojciech Dąbrowski
Journal:  Med Sci Monit       Date:  2014-02-24

8.  Kynurenic Acid Metabolism in Various Types of Brain Pathology in HIV-1 Infected Patients.

Authors:  H Baran; J A Hainfellner; B Kepplinger
Journal:  Int J Tryptophan Res       Date:  2012-12-13

9.  Effects of Various Kynurenine Metabolites on Respiratory Parameters of Rat Brain, Liver and Heart Mitochondria.

Authors:  Halina Baran; Katrin Staniek; Melanie Bertignol-Spörr; Martin Attam; Carina Kronsteiner; Berthold Kepplinger
Journal:  Int J Tryptophan Res       Date:  2016-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.